ViewRay's MRIdian system has already been installed at 30 leading hospitals around the world where it is being used to treat a wide variety of solid tumors and is the focus of numerous ongoing clinical trials. MRIdian has been the subject of hundreds of peer-reviewed publications, scientific meeting abstracts and presentations. More than 6,500 patients have been treated with MRIdian.
About ViewRay
Ad Statistics
Times Displayed: 45740
Times Visited: 1370 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
About GenesisCare in the UK:
GenesisCare delivers holistic oncology care at 14 specialist treatment centres in the UK, spanning radiotherapy, medical oncology, diagnostics, theranostics and wellness services. It is the largest provider of private cancer care services in the UK. Over the next two years, GenesisCare plans to open five new centres in the country, to increase patient access to world-class care when and where it's needed. Treatment is currently delivered in Birmingham, Bristol, Cambridge, Chelmsford, Elstree, Guildford, London, Maidstone, Milton Keynes, Nottingham, Oxford, Portsmouth, Southampton and Windsor.
SOURCE ViewRay, Inc.
Back to HCB News
